Summary
Changes in tension were monitored isometrically on spiral strips from human saphenous veins obtained during surgical removal of varicose veins. Concentration-response curves for noradrenaline and 5-hydroxytryptamine (5-HT) were established by cumulative administrations, curves for dihydroergotamine were constructed from the mean responses to single concentrations. The use of the antagonists prazosin, yohimbine and pizotifen provided evidence for the existence of both postjunctional α1- and α2-adrenoceptors and for the existence of 5-HT receptors. The venoconstrictor effects of dihydroergotamine were unchanged by prazosin. Yohimbine antagonized both dihydroergotamine and 5-HT at about 60 times higher concentrations than required against noradrenaline whereas pizotifen inhibited responses to both dihydroergotamine and 5-HT at about 100 times lower concentrations than those to noradrenaline.
These new results are in contrast to conclusions drawn from animal studies and do not support the suggestion that in man the venoconstrictor activity of dihydroergotamine is mediated through stimulation of α-adrenoceptors. The present results strongly suggest that in human saphenous veins the constrictor activity of dihydroergotamine is mediated at least in part through stimulation of 5-HT receptors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aellig WH (1973) Studies on the venoconstrictive effect of dihydroergotamine in man. Naunyn-Schmiedeberg's Arch Pharmacol 279: Suppl R43
Aellig WH (1974) Venoconstrictor effect of dihydroergotamine in superficial hand veins. Eur J Clin Pharmacol 7:137–139
Aellig WH (1976) Influence of ergot compounds on compliance of superficial hand veins in man. Postgrad Med J 52 Suppl:21–23
Aellig WH (1981) A new technique for recording compliance of human hand veins. Br J Clin Pharmacol 11:237–243
Ariens EJ, Simonis AM (1976) Receptors and receptor mechanism. In: Saxena PR, Forsyth RP (eds) Beta-adrenoceptor blocking agents. Elsevier North-Holland, Amsterdam, pp 3–27
Berde B, Stürmer E (1978) Introduction to the pharmacology of ergot alkaloids and related compounds as a basis of their therapeutic application. In: Berde B, Schild HO (eds) Ergot alkaloids and related compounds. Springer, Berlin Heidelberg New York, pp 1–28
Chu D, Stürmer E (1973) Studies on the mechanism of action of dihydroergotamine (DHE) on the vascular bed of cat skeletal muscle. Br J Pharmacol 48:331P-332P
Chu D, Owen DAA, Stürmer E (1976) Effects of ergotamine and dihydroergotamine on the resistance and capacitance vessels of skin and skeletal muscle in the cat. Postgrad Med J 52 Suppl 1: 32–36
Delius L, Hammerschmidt D, Odenthal F (1949) Klinisch-experimentelle Untersuchungen über die kreislaufdynamischen Wirkungen der dihydrierten Mutterkornalkaloide. Klin Wochenschr 27:33–34
DeMey JG, Vanhoutte PM (1980) Differences in pharmacological properties of postjunctional alpha-adrenergic receptors among arteries and veins. Arch Int Pharmacodyn 244:328–329
DeMey J, Vanhoutte PM (1981) Uneven distribution of post-junctional alpha1- and alpha2-like adrenoceptors in canine arterial and venous smooth muscle. Circ Res 48:875–884
Glusa E, Markwardt F (1982) Dual effect of dihydroergotamine and dihydroergotoxine in isolated human femoral veins and arteries. Pharmacology 24:287–293
Glusa E, Markwardt F (1983) Characterisation of postjunctional α-adrenoceptors in isolated human femoral veins and arteries. Naunyn-Schmiedeberg's Arch Pharmacol 323:101–105
Hammerschmidt D, Odenthal F (1950) Über die Wirkung der hydrierten Mutterkornalkaloide auf den arteriellen und venösen Blutdruck. Z Kreislaufforsch 39:150–160
Hilke H, Kanto J, Kleimola T, Mäntylä R (1978a) Intramuscular absorption of dihydroergotamine in man. Int J Clin Pharmacol 16:277–278
Hilke H, Kanto J, Mäntylä R, Kleimola T, Syvälahti E (1978b) Dihydroergotamine: pharmacokinetics and usefulness in spinal anaesthesia. Acta Anaesth Scand 22:215–220
Humphrey PPA (1978) The effects of α-adrenoceptor antagonists on contractile responses to 5-hydroxytryptamine in dog saphenous vein. Br J Pharmacol 63:671–675
Jauernig RA, Moulds RFW, Shaw J (1978) The action of prazosin in human vascular preparations. Arch Int Pharmacodyn 231:81–89
Kaumann AJ (1983) Yohimbine and rauwolscine inhibit 5-hydroxytryptamine-induced contraction of large coronary arteries of calf through blockade of 5-HT2 receptors. Naunyn-Schmiedeberg's Arch Pharmacol 323:149–154
Lange L, Echt M (1972) Vergleichende Untersuchungen über venentonisierende Pharmaka. Fortschr Med 90:1161–1164
Langer SZ, Shepperson NB (1981) Antagonism of alpha-adrenoceptor mediated contractions of the isolated saphenous vein of the dog by diltiazem and verapamil. Br J Pharmacol 74:942P-943P
Langer SZ, Shepperson NB (1982) Recent developments in vascular smooth muscle pharmacology: the post-synaptic α-adrenoceptor. TIPS 3:440–444
Lederballe Pedersen O, Mikkelsen E, Andersson KE (1979) Comparison of the in vitro effects of prazosin, nifedipine and dihydralazine in isolated human mesenteric and crural vessels. Arch Int Pharmacodyn 241:224–234
Mellander S (1971) Effects of selected vasoactive agents on resistance, exchange and capacitance vessels in skeletal muscle, In: Proc Symp physiol pharmacol vasc neuroeffector systems, Interlaken. Karger, Basel, pp 333–343
Mellander S, Nordenfelt I (1970) Comparative effects of dihydroergotamine and noradrenaline on resistance, exchange and capacitance functions in the peripheral circulation. Clin Sci 39:183–201
Müller-Schweinitzer E (1974) Studies on the peripheral mode of action of dihydroergotamine in human and canine veins. Eur J Pharmacol 27:231–237
Müller-Schweinitzer E (1983a) Tissue specific susceptibility of alpha-adrenoceptor mediated vasoconstriction to nifedipine. Naunyn-Schmiedeberg's Arch Pharmacol 324:64–69
Müller-Schweinitzer E (1983b) Vascular effects of ergot alkaloids: a study on human basilar arteries. Gen Pharmacol 14:95–102
Shepperson NB, Langer SZ (1981) The effects of 2-amino-tetrahydronaphthaline derivative M7, a selective α2-adrenoceptors agonist in vitro. Naunyn-Schmiedeberg's Arch Pharmacol 318:10–13
Stevens MJ, Moulds RFW (1981) Heterogeneity of post-junctional α-adrenoceptors in human vascular smooth muscle. Arch Int Pharmacodyn 254:43–57
Stevens MJ, Moulds RFW (1982) Are the pre- and postsynaptic α-adrenoceptors in human vascular smooth muscle atypical? J Cardiovasc Pharmacol 4:129–133
Sullivan AT, Drew GM (1980) Pharmacological characterisation of pre- and postsynaptic α-adrenoceptors in dog saphenous vein. Naunyn-Schmiedeberg's Arch Pharmacol 314:249–258
Thulesius O, Gjores JE, Berlin E (1979) Vasoconstrictor effect of midodrine, ST 1059, noradrenaline, etilefrine and dihydroergotamine on isolated human veins. Eur J Clin Pharmacol 16:423–424
Ulrich J, Siggaard-Andersen J (1971) Vascular effects of dihydrogenated ergot alkaloids. Comparative effects of dihydroergostine and dihydroergotamine on the blood flow and the capacitance vessels in the human calf studied by plethysmography. Angiology 22:622–628
Ulrich J, Jessen B, Siggaard-Andersen J (1973) Comparative effects of dihydroergotamine and hydergine on the blood flow, capillary filtration rate and the capacitance vessels in the human calf studied by plethysmography. Angiology 24:657–663
Van Rossum JM (1963) Cumulative dose-response curves (II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch Int Pharmacodyn 143:299–330
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Müller-Schweinitzer, E. Alpha-adrenoceptors, 5-hydroxytryptamine receptors and the action of dihydroergotamine in human venous preparations obtained during saphenectomy procedures for varicose veins. Naunyn-Schmiedeberg's Arch. Pharmacol. 327, 299–303 (1984). https://doi.org/10.1007/BF00506240
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00506240